MELISSA ROCK: Open Payments
NPI 1588011639 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,991 in 158 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $1,182 · 2025 $2,991
Food & beverage: $2,986Education: $5
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $516 |
| Lilly USA, LLC | 24 | $365 |
| ABBVIE INC. | 17 | $338 |
| PFIZER INC. | 14 | $284 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $237 |
| Sumitomo Pharma America, Inc. | 9 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $208 |
| Merck Sharp & Dohme LLC | 4 | $87 |
| Amgen Inc. | 4 | $85 |
| GlaxoSmithKline, LLC. | 3 | $67 |
Products named: MOUNJARO, Ozempic, QULIPTA, TRINTELLIX, GEMTESA, Wegovy, NURTEC ODT, Kerendia.
Industry payments across TX — which companies pay providers there.
